Many PNDs are associated with specific onconeural antibodies against intracellular antigens (Hu, Yo, Ri, CV2 (CRMP5), amphiphysin, Ma2), but there is considerable diversity such that no single antibody is associated with only one type of neurological presentation or underlying tumour (Pittock et al., 2004). Here, DPYSL5 is linked to neoplasm.